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Induction and Activation of the Transcription Factor
NFATc1 (NFAT2) Integrate RANKL Signaling
in Terminal Differentiation of Osteoclasts
The TRAF6 and c-Fos signaling pathways both play
important roles downstream of RANKL. We show here
that RANKL selectively induces NFATc1 expression
via these two pathways. RANKL also evokes Ca2 os-
cillations that lead to calcineurin-mediated activation
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et al., 1998; Naito et al., 1999; Kobayashi et al., 2001). that may induce the conjectured gene transcription pro-
gram during osteoclast differentiation. In this screening,Additionally, RANKL induces the expression of c-Fos
by an as yet unknown mechanism (Matsuo et al., 2000; we found that NFATc1, also referred to as NFAT2 or
NFATc (Rao et al., 1997), a member of the NFAT (nuclearWagner and Karsenty, 2001). In addition, negative regu-
lators of RANKL signaling have been reported, which factor of activated T cells) family of transcription factor
genes, is the most strongly induced transcription factorinclude osteoprotegerin (OPG), a soluble “decoy” recep-
tor for RANKL (Simonet et al., 1997), and interferon gene following RANKL stimulation. Transcription factors
of the NFAT family, originally discovered in the context(IFN)-, a negative regulator of c-Fos expression (Takay-
anagi et al., 2002). The essential role of these molecules of the activation of the immune system (Shaw et al.,
1988), are also involved in the function and developmentin maintaining bone homeostasis is fully underscored
by gene disruption studies (reviewed in Karsenty and of diverse cells in other biological systems, including
cardiovascular and musculoskeletal systems in verte-Wagner, 2002; Alliston and Derynck, 2002).
Cell differentiation often depends on extracellular brates, where they are under control of the Ca2-regu-
lated phosphatase, calcineurin (Berridge et al., 2000;stimuli that transmit signals to the cell interior so as to
induce the necessary gene transcription program(s). In Crabtree and Olson, 2002). However, their involvement
in bone remodeling, wherein RANKL-induced osteoclasteach developmental stage, transcription factors coordi-
nate to induce target genes essential for the survival differentiation plays a central role, is as yet unknown.
We provide evidence that NFATc1 expression is de-and maturation of the lineage. During the differentiation
process of hematopoietic stem cells to osteoclasts with pendent on both the TRAF6 and c-Fos pathways. We
also show that RANKL stimulation, but not IL-1 stimula-bone-resorbing activity, transcription factors such as
PU.1, c-Fos, NF-B, and MITF play a critical and specific tion, results in the induction of Ca2 oscillation, which
would contribute to the sustained activation of NFATc1role (Teitelbaum, 2000). Briefly, PU.1 is critical for the
early “determination” phase of bone marrow progenitor via a calcineurin-dependent mechanism. While the acti-
vated NFATc1 induces a number of genes involved incells to myeloid cells that respond to M-CSF (Tondravi
et al., 1997), and M-CSF-activated MITF is important for cell differentiation, NFATc1 also acts on its own gene to
amplify the NFATc1-mediated transcriptional program.Bcl-2 induction and survival of this lineage (Weilbaecher
et al., 2001; McGill et al., 2002). Both NF-B and c-Fos We provide data indicating the essential role of the
NFATc1 gene using a newly developed system for os-function downstream of RANKL signaling, and there is
genetic evidence that these factors play an essential teoclast differentiation in embryonic stem (ES) cell cul-
ture. We further demonstrate that ectopic expression offunction in the developmental stage from monocyte/
macrophage precursors to mature osteoclasts (Grigori- NFATc1 causes the BMMs to undergo efficient osteo-
clast differentiation in the absence of RANKL stimula-adis et al., 1994; Franzoso et al., 1997).
To date, little is known about how RANKL, but not tion. Finally, we provide evidence that NFATc1 cooper-
ates with c-Fos on the promoter of osteoclast-specificother cytokines that activate similar pathways, specifi-
cally induces terminal differentiation of osteoclasts genes. Collectively, our results show that NFATc1 plays
an integral role in the RANKL-induced transcriptionalthrough a specific transcriptional program. Several lines
program during the terminal differentiation of osteo-of evidence suggest hitherto unrecognized, critical
clasts. We will discuss our findings in the light of theevents downstream of the TRAF6 and c-Fos pathways.
intricate signaling network during RANKL-specific andFirst, the defect in osteoclast differentiation of TRAF6-
NFATc1-dependent osteoclast differentiation.deficient cells cannot be fully rescued by expressing a
TRAF6 mutant, by which NF-B activation still occurs
Results(Kobayashi et al., 2001). Although the essential role of
NF-B in osteoclastogenesis has been well documented
by gene disruption studies, this observation suggests Identification of mRNAs Selectively
Induced by RANKLthe presence of an additional function(s) of TRAF6. Sec-
ond, a similar defect in cells lacking c-Fos was shown To identify genes selectively activated by RANKL, we
performed a genome-wide screening of mRNAs in theto be rescued by the overexpression of one of its target
genes, Fra-1, but a recent conditional gene targeting BMMs with or without RANKL stimulation, using an oli-
gonucleotide array (Affymetrix GeneChip). When BMMs,study revealed that Fra-1 is not required for osteoclasto-
genesis (R. Eferl and E.F.W., unpublished data). Finally, obtained by culturing bone marrow cells in the presence
of M-CSF for 48 hr, were stimulated by recombinantthe TRAF6 and c-Fos pathways, as well as other RANKL-
activated molecules such as ERK, p38, and Akt, are also RANKL in the presence of M-CSF for 72 hr, as many as
30% of the cells undergo differentiation into osteoclastsactivated by various other cytokines, such as IL-1 (Cao
et al., 1996; Reddy et al., 1997; Ninomiya-Tsuji et al., with bone-resorbing activity (Takayanagi et al., 2000b).
Total RNA was extracted 2, 24, and 72 hr after RANKL1999), which are not capable of inducing osteoclast dif-
ferentiation. These observations in toto suggest that stimulation of BMMs. At the same time points, total RNA
was also isolated from mock-stimulated BMMs or BMMsRANKL signaling activates an as yet unknown path-
way(s) that specifically invokes the transcriptional pro- stimulated by IL-1 instead of RANKL, in order to com-
pare mRNA expression profiles. As shown in Figure 1A,gram leading the cells to undergo terminal differenti-
ation. mRNAs known to be strongly expressed in osteoclasts,
that is, those of tartrate-resistant acid phosphataseTo gain insight into the mechanism of the RANKL-
specific induction of the osteoclast differentiation pro- (TRAP), calcitonin receptor, cathepsin K, carbonic anhy-
drase II (CAII), and matrix metalloprotease (MMP)-9,gram, we took a genome-wide screening approach to
identify genes specifically induced by RANKL, but not were specifically induced by RANKL, confirming the va-
lidity of our screening protocol.by IL-1. In particular, we focused on transcription factors
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Figure 1. Genome-Wide Screening of RANKL-Inducible Genes by GeneChip
(A) Evaluation of the screening system by the expression profiles of the genes that are known to be highly expressed in osteoclasts. As
summarized here, these genes were specifically and strongly induced by RANKL. The left panel shows mRNA expression level (indicated as
average difference) and the right panel shows the fold increases in the mRNA expression level compared with that in unstimulated cells.
GeneChip analysis was repeated several times, and yielded similar results; a representative set of data is shown.
(B) A list of the genes encoding transcription factors that are highly induced by RANKL or are suggested to act downstream of the RANKL
signaling pathway. The level and the fold induction of the mRNA expression were most notable for NFATc1.
To gain insight into the transcriptional program in- stimulation by IL-1, and such induction was not ob-
served in mRNAs for the other NFAT members. mRNAsduced by RANKL, we focused on the induction of genes
encoding transcription factors. As shown in Figure 1B, for the other transcription factors such as c-Fos and
Fra-1, which are involved in osteoclast differentiation,the most notable gene was NFATc1. In fact, NFATc1
mRNA was not induced by M-CSF alone or by additional are also selectively induced by RANKL, albeit at much
Developmental Cell
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Figure 2. Expression of NFATc1 mRNA and
Protein during and after Osteoclast Differenti-
ation
(A) RNA blotting analysis of NFATc1 mRNA.
Total RNA was extracted from BMMs stimu-
lated with RANKL/M-CSF for the indicated
periods. Five micrograms of total RNA was
applied to each lane.
(B) Immunostaining of NFATc1 protein in
BMMs stimulated with RANKL/M-CSF.
NFATc1 is initially induced in the cytoplasm,
and gradually translocalizes into the nucleus.
Note the marked NFATc1 expression in multi-
nucleated osteoclasts. Nuclei are stained by
DAPI in the lower panel.
(C) In vivo expression of NFATc1 in osteo-
clasts. Serial sections of proximal tibia from
8-week-old C57BL/6 mice were stained by
TRAP and hematoxylin or immunostained by
the anti-NFATc1 antibody followed by the
Alexa 488-conjugated secondary antibody.
lower levels (Figure 1B). Consistent with this result, RNA members such as NFATc2 and NFATc3 was undetect-
able in these cells (see Supplemental Figure S1 at http://blotting analysis revealed that robust induction of
NFATc1 mRNA occurred in BMMs, culminating 48 hr www.developmentalcell.com/cgi/content/full/3/6/889/
DC1), further suggesting the role of NFATc1 in vivo.after RANKL stimulation. At this time point, mRNA ex-
pression was more than 20-fold of the basal level, and
was sustained thereafter (Figure 2A). Requirement of the TRAF6 and c-Fos Pathways
in RANKL-Induced NFATc1 Expression
In view of the previous results demonstrating that theExpression of NFATc1 and Its Localization
TRAF6 and c-Fos signaling pathways are both criticalduring Osteoclast Differentiation
for osteoclast differentiation, it is an interesting issueWe next examined the expression and cellular localiza-
whether NFATc1 induction is linked to either or both oftion of the NFATc1 protein in RANKL-stimulated BMMs
these pathways. We therefore examined the RANKL-undergoing terminal differentiation into multinucleated
induced expression of NFATc1 mRNA and protein inosteoclasts. As shown in Figure 2B, immunofluo-
osteoclast precursor cells derived from mice lackingrescence staining revealed that the NFATc1 protein ex-
TRAF6 or c-Fos (TRAF6/ or Fos/ mice). As shown inpression level increased continuously, followed by its
Figure 3A, the induction of NFATc1 mRNA by RANKLnuclear translocation, during the RANKL-induced differ-
was abolished in the cells lacking c-Fos, and it alsoentiation of BMMs to osteoclasts. In fact, the expression
decreased significantly (to approximately one-fourth) inof NFATc1 is dominant in the cytoplasm at 24 hr after
the cells lacking TRAF6. As expected, the NFATc1 pro-RANKL stimulation, but its nuclear translocation be-
tein was not detectable in the Fos/ cells after RANKLcomes apparent at 48 hr, when cellular fusion character-
stimulation, as revealed by immunofluorescence stain-istic of osteoclasts initiates (Figure 2B). At this time
ing. Notably, the NFATc1 protein was also barely detect-point, cells positive for TRAP, diagnostic for osteoclasts,
able in the TRAF6/ cells (Figure 3B). Although the de-can already be observed (data not shown). At 72 hr
tailed mechanisms underlying this process need furtherafter RANKL stimulation, essentially all the nuclei of the
clarification, these results indicate that the induction ofmultinucleated cells (MNCs) fully expressing the TRAP
NFATc1 by RANKL is dependent on the two signalingmarker became strongly positive for NFATc1 (Figure 2B).
pathways bifurcated from RANK.Thus, there is a close correlation between the kinetics
of RANKL-induced increase in NFATc1 expression level
in nuclei and differentiation of BMMs to osteoclasts in Induction of Ca2 Signaling
in RANKL-Stimulated Cellsvitro. Consistently, the in vivo histological examination
of the bone tissue also revealed that NFATc1 is specifi- The activities of transcription factors of the NFAT family
are regulated by the calcium (Ca2)/calmodulin-depen-cally expressed in TRAP-positive cells, characteristic of
osteoclasts (Figure 2C). As expected, NFATc1-positive dent calcineurin, a serine/threonine phosphatase, which
allows nuclear translocation of these transcription fac-cells also expressed cathepsin K or MMP-9 (data not
shown). On the other hand, expression of other NFAT tors (Rao et al., 1997; Berridge et al., 2000; Crabtree
NFATc1 in Osteoclast Differentiation
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Figure 3. NFATc1 Expression Is Dependent
on the TRAF6 and c-Fos Pathways
(A) Expression of NFATc1 mRNA in Fos/ and
TRAF6/ cells stimulated with RANKL and
M-CSF (RNA blotting analysis). NFATc1
mRNA was not induced in Fos/ cells, and
the induction was significantly decreased in
TRAF6/ cells.
(B) Expression of NFATc1 protein in Fos/
and TRAF6/ cells stimulated with RANKL
and M-CSF. M-CSF-treated precursor cells
derived from splenocytes were further stimu-
lated with RANKL/M-CSF for 3 days, and
were immunostained with the anti-NFATc1
antibody. Multinucleated osteoclasts were
formed only in WT precursor cells, and these
multinucleated cells strongly express
NFATc1. NFATc1 protein expression was ab-
sent or very weak in the RANKL-stimulated
Fos/ and TRAF6/ cells, respectively.
and Olson, 2002). Since NFATc1 induced by RANKL RAW 264.7 cells, a macrophage cell line that differenti-
ates into osteoclasts in response to RANKL alone (dataundergoes efficient nuclear translocation (Figure 2B),
one may envisage the Ca2-dependent activation of cal- not shown). Interestingly, FK506 not only inhibited the
nuclear translocation of NFATc1, but also suppressedcineurin by RANKL. Interestingly, a sustained Ca2 oscil-
lation was observed in BMMs stimulated by RANKL, the increase in NFATc1 expression levels (Figure 4D).
RNA blotting analysis shows that induction of NFATc1which was not observed in IL-1-stimulated BMMs (Fig-
ure 4A). Neither Ca2 oscillation nor a Ca2 spike was mRNA was also inhibited by FK506 (Figure 4E). Our
results suggest in toto that RANKL stimulation inducesinduced immediately after RANKL stimulation. Rather,
the RANKL-induced Ca2 oscillation initiated as late as the calcineurin-dependent autoamplification of NFATc1
expression, through NFATc1-dependent NFATc1 gene24 hr after RANKL stimulation, that is, when NFATc1
induction becomes notable; the oscillation was sus- transcription, so as to sustain the NFATc1-mediated
gene transcription program during the terminal differen-tained thereafter, provided that RANKL was present
(data not shown; see the legend for Figure 4A). It may tiation of osteoclasts (see also below).
be worth noting that Ca2 ionophores such as PMA and
ionomycin, instead of RANKL, caused neither NFATc1
Essential Role of NFATc1 in RANKL-Inducedinduction nor osteoclast differentiation in the presence
Osteoclast Differentiationof M-CSF alone or in combination with IL-1 (data not
The above observations strongly suggest that NFATc1,shown). This observation suggests that sustained Ca2
which is induced and activated by RANKL, is essentialoscillation, rather than transient activation of a Ca2
for osteoclast differentiation. In order to address thisspike, is necessary for the sustained NFATc1 activation
issue further, we examined whether a loss-of-functionduring osteoclastogenesis.
mutation in NFATc1 alleles affects the differentiation of
osteoclasts. Since mice carrying such a mutation are
lethal at day 14.5 of gestation (de la Pompa et al., 1998;Activation of NFATc1 and Autoamplification
of NFATc1-Mediated Transcription Ranger et al., 1998), we developed a new, feeder cell-
independent culture system of ES cells for an osteoclastThe above results showing the induction of Ca2 oscilla-
tion by RANKL stimulation suggest its critical involve- formation assay. In this system, ES cells first differenti-
ate into monocyte/macrophage progenitor cells in thement during the terminal differentiation of osteoclasts,
wherein NFATc1 would be constantly activated through presence of M-CSF, and these cells then undergo osteo-
clast differentiation by RANKL stimulation (Figure 5A).the Ca2-dependent calcineurin pathway. This notion
is supported by the following two observations. First, To maintain the microenvironments suitable for hemato-
poietic cell development, we performed a three-dimen-BAPTA-AM, a selective Ca2 chelator, strongly inhibited
RANKL-induced osteoclastogenesis as well as induc- sional culture by formation of an embryoid body (EB;
Hidaka et al., 1999). After a 2 day stimulation of the EBstion of NFATc1 (Figure 4B). Second, FK506 and cyclo-
sporin A (CsA), the specific inhibitors of calcineurin (Liu by M-CSF, the development of monocyte/macrophage
progenitor cells was observed, and these cells wereet al., 1991), also inhibited RANKL-induced osteoclast
differentiation from BMMs in a dose-dependent manner enzymatically dispersed and seeded into new culture
dishes. When these cells were stimulated by RANKL in(Figure 4C). The same inhibitory effect was observed in
Developmental Cell
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Figure 4. Regulation of NFATc1 by Cal-
cineurin and Ca2 Signaling
(A) Ca2 oscillation observed in RANKL-
treated BMMs. BMMs were incubated with
RANKL or IL-1 in the presence of M-CSF for
72 hr. Oscillations were observed about
24–72 hr after RANKL stimulation. The upper
panel shows an example of successive pseu-
docolored Ca2 images of a cell treated with
RANKL for 24 hr. Note that the cell loaded
with fluo-4 shows oscillation with a frequency
of about a 2 min interval. The lower panel
shows traces of [Ca2]i change in single cells
treated with RANKL (left) or IL-1 (right) for 72
hr. [Ca2]i change in cells coloaded with
fluo-4 and Fura Red were estimated as the
ratio of fluorescence intensity of the fluo-4
to Fura Red, and the percent maximum ratio
increase from the baseline was plotted with
an interval of 5 s. Maximum ratio increase
was obtained with the addition of 10M iono-
mycin at the end of each experiment, indi-
cated by an arrow. Each color indicates a
different cell in the same field, and [Ca2]i in
only RANKL-treated cells are oscillating.
(B) The calcium chelator, BAPTA-AM, sup-
presses RANKL-induced osteoclastogenesis
in BMMs. Note that NFATc1 induction is also
severely suppressed.
(C) Suppressive effects of calcineurin inhibi-
tors, FK506 and cyclosporin A, on RANKL-
induced osteoclastogenesis in BMMs. For-
mation of TRAP-positive multinucleated cells
(TRAP MNCs) was inhibited dose depen-
dently.
(D) FK506 inhibits RANKL-induced nuclear
translocalization and enhanced expression of
NFATc1 in a dose-dependent manner. Nu-
clear localization of NFATc1 was strongly in-
hibited by as low as 0.1 g/ml, accompanied
with significant reduction in the osteoclast
number as shown in (C).
(E) Inhibition of RANKL-activated induction
of NFATc1 mRNA by FK506 (10 g/ml); RNA
blotting analysis. See text and Experimental
Procedures for details.
the presence of M-CSF for 4 days, differentiation of NFAT gene members at the stage when monocyte/mac-
rophage precursor cells, developed from ES cells, un-osteoclasts was observed, with an efficiency of about
dergo further differentiation into osteoclasts following50% compared to that of BMMs (data not shown), based
RANKL stimulation.on the TRAP-positive and multinucleated phenotypes
and the bone-resorbing activity on dentine slices (Fig-
ure 5B). Induction of Osteoclast Differentiation
We then subjected NFATc1/ ES cell lines, generated by Ectopic Expression of NFATc1
from NFATc1/ ES cells by selection at a high G418 In order to further investigate the role of NFATc1, we also
concentration (Yoshida et al., 1998), to the osteoclast examined the effect of an ectopic NFATc1 expression in
differentiation assay. The M-CSF-dependent generation BMMs. We constructed a retrovirus vector, pMX-
of monocyte/macrophage precursor cells positive for NFATc1-IRES-EGFP, which is engineered to express
CD11b (Mac-1) or nonspecific esterase (NSE) was ob- both NFATc1 and green fluorescence protein (GFP).
served in NFATc1/ ES cells at a level similar to that in Then, BMMs were infected with the NFATc1-expressing
the case of parental NFATc1/ ES cells (Figure 5C). virus (denoted as pMX-NFATc1 in Figure 6) or other
However, these mutant cells failed to differentiate fur- viruses expressing either c-Fos (pMX-c-fos-IRES-EGFP)
ther into osteoclasts by RANKL stimulation (Figure 5B). or c-Jun (pMX-c-jun-IRES-EGFP), or with a control virus
The expression levels of c-Fms (M-CSF receptor) and (pMX-IRES-EGFP) (see Experimental Procedures for de-
RANK on NFATc1/ precursor cells were comparable tails). Surprisingly, the expression of NFATc1 in BMMs
to that on NFATc1/ precursor cells (data not shown). caused efficient induction of osteoclast differentiation
These results collectively suggest that the NFATc1 gene even without RANKL stimulation (Figures 6A and 6B).
Actually, as many as about 70% of the cells positive foris indispensable, and hence cannot be replaced by other
NFATc1 in Osteoclast Differentiation
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Figure 5. Requirement of NFATc1 for ES
Cells Undergoing Osteoclast Differentiation
(A) A schematic illustration of the ES cell cul-
ture system for generating osteoclasts. Under
LIF-depleted conditions, embryoid bodies
(EBs) were formed by the hanging drop
method. These EBs were stimulated by 100
ng/ml M-CSF for 2 days. The EBs were then
treated with trypsin to obtain single cells,
which were reseeded and cultured for 4 days
in the presence of 100 ng/ml RANKL and 10
ng/ml M-CSF.
(B) ES cells lacking NFATc1 are defective in
osteoclast formation. Formation of TRAP
MNCs in NFATc1/ ES cell cultures on day
8 (left), and the absence of TRAP MNCs in
NFATc1/ ES cell cultures (right) are shown.
NFATc1/ ES cells underwent differentiation
into TRAP cells, which are multinucleated
(upper) and have bone-resorbing activity on
dentine slices (lower). As expected, these
MNCs highly express NFATc1 (not shown).
(C) Differentiation of NFATc1/ and
NFATc1/ ES cells into monocyte/macro-
phage precursor cells. CD11b is equally ex-
pressed on the cells obtained after M-CSF
stimulation in EBs on day 4 (left). Nonspecific
esterase (NSE) colonies are also equally
formed in both cultures (right, day 8).
GFP underwent differentiation into TRAP cells, which the terminal differentiation of osteoclasts, contain multi-
have bone-resorbing activity (Figure 6B; data not ple NFAT and AP-1 binding sites (Reddy et al., 1995;
shown). On the other hand, only 7% and 1% of the GFP- Anusaksathien et al., 2001; Motyckova et al., 2001; David
positive cells underwent differentiation into TRAP cells et al., 2001). NFAT is known to cooperate with AP-1 by
by c-Fos and c-Jun expression, respectively (Figure 6A). forming a complex (Chen et al., 1998; Macia´n et al.,
As expected from the data in Figure 3 showing the re- 2000, 2001). Since NFATc1 and c-Fos, one of the major
quirement of both c-Fos and TRAF6 pathways for effi- components of AP-1, are both induced by RANKL, we
cient NFATc1 expression, NFATc1 expression induced reasoned that NFATc1 and c-Fos might cooperate with
by c-Fos-expressing virus remained very low (Figure 6C). each other on these osteoclast-specific promoters. We
Thus, the ectopic NFATc1 expression causes efficient then examined activation of the TRAP promoter, which
osteoclast differentiation even in the absence of RANKL. is characterized for its NFAT and AP-1 binding sites
Interestingly, this NFATc1-driven osteoclast differentia- (Reddy et al., 1995) by a transient assay in 293T cells.
tion is partially resistant to FK506 (Figure 6D; left panel). pTRAP-luc, in which the TRAP promoter is linked to the
In addition, the thus expressed NFATc1 is detected in luciferase reporter gene, was cotransfected with either
the nuclei of those cells that underwent differentiation an NFATc1 cDNA expression vector (Sherman et al.,
despite the presence of FK-506 (Figure 6D; right panel). 1999), Fos cDNA expression vector, or both.
These observations are distinct from those of the As shown in Figure 6F (lower panel), expression of
RANKL-stimulated cells, in which FK506 completely in- NFATc1 caused a significant induction of luciferase ac-
hibits these events at the same concentration (Figure tivity. Although c-Fos alone had little effect on this pro-
4C). Furthermore, in the BMMs expressing the virus- moter, coexpression of NFATc1 and c-Fos had a syner-
encoded NFATc1, induction of NFATc1 mRNA from the gistic effect on luciferase expression. To investigate the
endogenous NFATc1 gene is detected (Figure 6E), indi- critical role of the interaction between these transcrip-
cating that the ectopic NFATc1 expression results in the tion factors, we constructed a cDNA expression vector
NFATc1-dependent NFATc1 gene induction. for an NFATc1 mutant (NFATc1RL) that would affect its
interaction with c-Fos (see Chen et al., 1998; Macia´n et
al., 2000). Coimmunoprecipitation experiments revealedTranscriptional Targets and Partners of NFATc1
that the interaction of NFATc1 with c-Fos is markedlyGenes such as TRAP, calcitonin receptor, cathepsin K,
CAII, and MMP-9, which are specifically induced during enhanced by coexpressing the two cDNAs, but such
Developmental Cell
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Figure 6. Induction of Osteoclastogenesis
and Promoter Activation by NFATc1
(A) Retroviral expression of NFATc1 induces
osteoclasts in the absence of RANKL. Induc-
tion efficiency is indicated as a ratio of TRAP
cell number to the number of transfected cells
positive for GFP. These TRAP cells have
bone resorption activity on dentine slices (not
shown).
(B) TRAP staining of BMMs transfected with
either pMX-NFATc1 or pMX-EGFP. Note that
the TRAP cells are multinucleated in pMX-
NFATc1-transfected cells (see also [C] and
[D], upper right panel).
(C) NFATc1 expression in BMMs transfected
with pMX-NFATc1, pMX-EGFP, or pMX-c-
fos. Note that transfection with pMX-NFATc1
results in NFATc1 expression at a level much
higher than that with pMX-c-fos. See text for
details.
(D) Effect of FK506 (1 g/ml) on the osteo-
clastogenesis induced by ectopic NFATc1
expression and cellular localization of the
NFATc1 protein. FK506 partially inhibited the
retrovirus-mediated osteoclastogenesis (left).
Alexa 594-stained NFATc1 is localized in the
nuclei (stained with DAPI) as well as in the
cytoplasm in NFATc1 virus-infected cells. Even
in the presence of FK506, retrovirus-induced
NFATc1 is still detectable in the nuclei of os-
teoclasts, albeit at lower levels (right).
(E) Induction of endogenous NFATc1 gene
by virally expressed NFATc1. Total RNA was
extracted from BMMs 5 days after transfec-
tion with NFATc1 or EGFP virus. RT-PCR
primers were designed to detect the mRNA
transcript from the endogenous NFATc1
gene, but not the virus-derived cDNA. In
this figure, endo denotes endogenously ex-
pressed mRNA .
(F) NFATc1 cooperates with c-Fos in the
activation of the TRAP promoter. Coexpression of the wild-type NFATc1 and c-Fos results in a synergistic activation of the TRAP promoter
in 293T cells (lower panel). On the other hand, such activation was not seen with an NFATc1 mutant defective in forming a complex with
c-Fos (NFATc1RL) (see upper panel).
(G) Activation of the TRAP promoter by RANKL in RAW 264.7 cells. RANKL stimulation causes activation of the promoter, and this activation
is inhibited by FK506 or by coexpression of the NFATc1RL mutant (left). Furthermore, synergistic activation of the promoter is observed when
the cells were cotransfected with the reporter gene and NFATc1-expressing vector, and then stimulated with RANKL (right). This activation
is also inhibited by FK-506.
enhancement was not observed with the NFATc1 mu- the context of AP-1, in order to activate the transcription
of osteoclast-specific genes.tant, suggesting that this mutant has a defect in forming
a complex with c-Fos (Figure 6F, upper panel). As shown
in Figure 6F, this NFATc1 mutant was less effective in Discussion
the activation of the promoter compared to the wild-
type NFATc1 and, more importantly, coexpression of Induction of NFATc1 by the RANKL/RANK-
Associated Signaling Pathwaysc-Fos had virtually no effect. Using the same reporter
construct, we found that RANKL stimulation caused the RANKL signaling is known to be essential for osteoclast
differentiation, at the stage after the commitment of theactivation of this promoter in RAW 264.7 cells. This acti-
vation is inhibited by NFATc1RL and by FK506, indicat- bone marrow progenitor cells into the myelomonocytic
lineage (Arai et al., 1999). However, it remains elusiveing that NFATc1 induced by RANKL is indeed transcrip-
tionally active (Figure 6G, left panel). Furthermore, when how RANKL, in the face of similar functions of other
cytokines, specifically transmits the differentiation sig-the cells were cotransfected with the reporter gene and
NFATc1-expressing vector and then stimulated with nal(s) to determine the fate of cells. In this study, we
demonstrated that RANKL, but not IL-1 or M-CSF, in-RANKL, the promoter was synergistically activated, and
this activation was also inhibited by FK-506 (Figure 6G, duces NFATc1 expression in primary BMMs, and that
this induction was impaired in both TRAF6/ and Fos/right panel). Similar results were observed with the calci-
tonin receptor promoter, which also contains NFAT and cells. Previous gene disruption studies revealed the es-
sential role of c-Fos and TRAF6-dependent NF-B path-AP-1 binding sites (data not shown). These results also
lend support to the notion that RANKL-induced NFATc1 ways, bifurcating from the RANKL receptor, RANK, and
it was thought that these pathways act in concert tocooperates with the similarly induced c-Fos, perhaps in
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evoke the downstream transcriptional program(s) (re- induction of Ca2 oscillation may be triggered indirectly
by a molecule(s) that is induced by RANKL. In supportviewed in Karsenty and Wagner, 2002).
It is interesting that both AP-1 and NF-B binding of this possibility, we have preliminary results that the
supernatant of RANKL-stimulated BMMs has a stimula-sites are present within the promoter region of the
NFATc1 gene (Zhou et al., 2002). It is therefore possible tory effect on osteoclastogenesis and Ca2 signaling,
which was not suppressed by OPG (S.K. and H.T., un-that the initial induction of the gene is mediated by these
two transcription factors, which is then followed by published data). Further study will be required to eluci-
date the detailed mechanism of the RANKL-inducedNFATc1-mediated autoamplification of gene induction.
This may explain, at least in part, why gene transcription Ca2 oscillation, which was previously found in fertilized
eggs and other cells (Berridge et al., 2000; Crabtree andis dependent on both c-Fos and TRAF6. In addition, in
view of very weak expression of the NFATc1 protein in Olson, 2002).
However, whatever the mechanism, it is clear thatthe RANKL-stimulated TRAF6/ cells (Figure 3B), it is
possible that the TRAF6 pathway is also involved in the Ca2/calcineurin pathway is an essential pathway
associated with RANKL signaling. The sustained activa-the regulation of NFATc1 protein expression. On the
contrary, the expression of TRAF6 and c-Fos was normal tion of NFATc1, mediated by a low-level Ca2 oscillation,
may be necessary during the entire differentiation pro-in NFATc1-deficient monocyte/macrophage precursor
cells (data not shown). Collectively, these results indi- cess. Indeed, continuous RANKL stimulation is neces-
sary until the BMMs reach the final stage of differentia-cate that efficient NFATc1 induction is a result of integra-
tion of the two signaling pathways bifurcated from tion (data not shown). It has been reported that
differential activation of transcription factors is contin-RANK, that is, that the NFATc1 gene is the convergent
target of the two pathways. gent on the calcium signaling pattern; NFATs are acti-
vated by a low, but sustained Ca2plateau (Dolmetsch et
al., 1997), and that Ca2 oscillations reduce the effectiveInduction of Ca2 Signal by RANKL
Ca2 threshold for activation of transcription factorsand NFATc1 Activation
(Dolmetsch et al., 1998). Our findings are congruent withOur study also demonstrates a pathway uniquely linked
these reports in that sustained Ca2 oscillation ensuresto RANKL signaling, that is, induction of Ca2 oscillation,
the NFATc1-mediated transcriptional program in RANKL-which is not observed when the cells were stimulated
stimulated BMMs.by IL-1 (Figure 4A). In view of the strong inhibitory effects
of FK506 and CsA, as well as BAPTA-AM, on NFATc1
expression, NFATc1 gene induction is apparently de-
Critical Function of NFATc1 in the Osteoclastpendent on Ca2-dependent calcineurin activation. It
Differentiation Programhas been reported that in T cells, NFATc2 induces the
Using NFATc1-deficient ES cells, we demonstrated thatNFATc1 gene, the promoter of which contains the NFAT
the NFATc1 gene is essential for RANKL-induced osteo-binding site (Zhou et al., 2002). Our results indicate that
clast differentiation. Consistently, NFATc1, but notthis autoamplification mechanism of the NFATc1 gene,
NFATc2 or NFATc3, is expressed by osteoclasts in vivoaccompanied by Ca2 oscillation, also operates in the
(Figure 2C; Supplemental Figure S1). Although furtherBMMs. This would lead to the robust induction of the
studies are necessary to rigorously assess the in vivoNFATc1-mediated transcriptional program, which is
mechanism, these results point to the indispensable,specifically conferred to RANKL signaling. It has been
selective role of NFATc1 in bone metabolism, andreported that Ca2 oscillation is observed shortly after
strongly suggest that a similar mechanism is also opera-TNF- stimulation in neutrophils (Schumann et al., 1993).
tional in vivo. Since NFATc1 induction is abolished ifHowever, Ca2 oscillation was minimal, if at all, in the
FK506 and RANKL are added at the same time, theTNF--treated BMMs, and the induction of NFATc1 by
calcineurin-mediated NFATc1 activation is critical forTNF-was much lower than that by RANKL (see Supple-
autoamplification of the NFATc1 gene at an early phasemental Figure S2). This may explain, at least in part, why
(Figure 4E). In addition, when FK506 is added to BMMsTNF- cannot fully induce osteoclast differentiation, but
48 hr after RANKL stimulation, osteoclastogenesis wasacts in synergy with RANKL in osteoclast differentiation
also inhibited completely (data not shown) despite the(Lam et al., 2000). Interestingly, other NFAT family genes
presence of NFATc1, indicating the importance of sus-also contain NFAT binding sites within their promoters,
tained NFATc1 activation throughout the differentiationbut these genes are not induced in RANKL-stimulated
process. After completion of this study, a report wasBMMs (Figure 1A; and H.T., unpublished observation).
published pointing to the role of NFATc1 induction byIt is as yet unknown how RANKL induces Ca2 oscilla-
RANKL in the differentiation of RAW 264.7 cells intotion in the cell. The best-known mechanism is the activa-
TRAP multinucleated cells (Ishida et al., 2002). Thus,tion of phospholipase C (PLC), followed by the release
their observations are consistent with our results, ob-of inositol 3-phosphate (IP3), which triggers intracellular
tained with primary BMMs.Ca2 release and extracellular Ca2 influx (Berridge et
From the above viewpoint, it is interesting that BMMsal., 2000). This mechanism may operate in both the im-
undergo osteoclast differentiation in the absence ofmune and cardiovascular systems, in which distinct ex-
RANKL, when NFATc1 is expressed ectopically in thesetracellular stimuli induce the PLC cascade. We currently
cells. It is well documented that the cellular localizationhave no evidence that RANKL directly induces PLC acti-
of NFAT family members is under tight control at multiplevation (H.T., unpublished observation). The oscillation
levels (Macia´n et al., 2001; Crabtree and Olson, 2002).initiates as late as 24 hr following the ligand stimulation,
We infer that a high NFATc1 expression level partiallypreceded by induction and activation of c-Fos and NF-
B, respectively. Therefore, it is possible that RANKL overrides this negative regulatory machinery. In fact,
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NFATc1 is detected in the nuclei of these cells, sug- cooperate with NFATc1 in the cells cultured in the pres-
ence of M-CSF. In this regard, c-Fos is detected to agesting an equilibrium shift of NFATc1 localization be-
tween the nucleus and the cytoplasm in these cells (Fig- certain extent in those cells even before RANKL stimula-
tion (Figure 1B; see also Takayanagi et al., 2002). It isure 6D). Our results showing that FK506 inhibits only
partially the cell differentiation caused by the ectopically known that AP-1 proteins are induced by various intra-
cellular signaling molecules such as Ras and MAP ki-expressed NFATc1 support this view. Alternatively, we
cannot rigorously rule out the possibility that the retrovi- nases, both of which are activated by M-CSF (Bourette
and Rohrschneider, 2000). Thus, the level of ectopicallyrus-driven NFATc1 cDNA expression results in the pro-
duction of a calcineurin-independent form of NFATc1, expressed NFATc1, directed by the virus-encoded
cDNA, may be the major limiting factor for initiation of thewhich may be similar to the previously constructed mu-
tant (Timmerman et al., 1996). On the other hand, partial differentiation program by the NFATc1:AP1 complex.
Clearly, NFATc1 needs the AP-1 component undersuppression of this differentiation by FK506 also sug-
gests that, unlike other cells such as resting T cells, physiological conditions, such as RANKL-induced dif-
ferentiation of BMMs into osteoclasts. It remains to bethese BMMs retain certain level of calcineurin activities,
possibly through cellular stimulation by other molecules clarified whether NFATc1 also needs the cooperation of
other transcription factors, such as NF-B and GATAin the cell culture.
Whatever the detailed mechanism underlying the family members, which also interact with NFAT family
members (Macia´n et al., 2001).above process, our results indicate that once the
NFATc1 expression level reaches above the threshold,
the ectopically expressed NFATc1 also induces NFATc1 Therapeutic Implications
from the endogenous gene (Figure 6E). Thus, NFATc1 The essential role of NFATc1 induction and activation
may represent a master regulator of RANKL-induced by RANKL in osteoclast differentiation described in this
osteoclast differentiation, switching on the transcrip- study may offer an auspicious target for therapy in bone
tional program for the terminal differentiation of osteo- diseases caused by excessive bone resorption. Sys-
clasts, wherein the autoamplification of NFATc1 inti- temic effects of FK506 and CsA on bone mass is not
mately participates in sustaining the program. always advantageous (Cvetkovic et al., 1994; Leidig-
This study further supports the contention of Crabtree Bruckner et al., 2001), and this may be caused by their
and colleagues that members of the NFAT family effect on the other cell types such as osteoblasts or T
evolved to meet the specialized needs of vertebrate cells (Buchinsky et al., 1996). Therefore, these cal-
development (Crabtree and Olson, 2002). RANKL signal- cineurin inhibitors may be beneficial if we can develop
ing is also known to be essential in the development of the methods that would allow the delivery of these drugs
the mammary gland and immune system, or organiza- selectively to the osteoclast lineage. If one could identify
tion of lymph nodes (Fata et al., 2000; Kong et al., 1999). a specific molecule(s) involved in RANKL-induced Ca2
Although the detailed mechanism of this RANKL-medi- oscillation, an alternative therapeutic target(s) of bone
ated organogenesis is still unknown, the RANKL-associ- diseases may become available. In addition, targeting
ated NFATc1 pathway described here may also be in- NFATc1 activity by inhibiting the interaction of NFATc1
volved in these processes. and AP-1 may be an interesting strategy.
Experimental ProceduresCooperation of NFATc1 and Other
Transcription Factors
In Vitro OsteoclastogenesisUsing a transient assay, we provide evidence that the
Nonadherent bone marrow cells derived from C57BL/6 mice were
formation of a complex between NFATc1 and c-Fos, seeded (5  104 cells per well in a 24-well plate, 1.5–2.0 107 cells
presumably in the context of AP-1, is critical for the in a 10 cm dish) and cultured in -MEM (GIBCO-BRL) with 10%
FBS (Sigma) containing 10 ng/ml M-CSF (Genzyme). After 2 days,activation of the genes involved in osteoclastogenesis.
adherent cells were used as BMMs after washing out the nonadher-Therefore, we infer that a mechanism similar to that of
ent cells including lymphocytes. Monocyte/macrophage progenitorthe immune and other systems (Chen et al., 1998; Ma-
cells of Fos/ and TRAF6/ mice were derived from the spleen andcia´n et al., 2000, 2001) is also operational during osteo-
similarly cultured with 10 ng/ml M-CSF for 2 days. These osteoclast
clast differentiation. This cooperation between NFATc1 precursor cells were further cultured in the presence of 100 ng/
and c-Fos may also be critical for the autoamplification ml soluble RANKL (Peprotech) and 10 ng/ml M-CSF to generate
osteoclasts; we used these reagents at these concentrations unlessof the NFATc1 gene (see Figure 3A). Consistently, we
otherwise indicated. Calcineurin inhibitors, FK506 (Calbiochem) oralso observed a synergistic effect of retrovirus vectors
cyclosporin A (Sigma), were added at the same time with RANKL.carrying NFATc1 and Fos on osteoclastogenesis, sug-
Three days later, TRAP multinucleated (3 nuclei) cells weregesting that this cooperation indeed contributes to cell
counted. All data are expressed as mean 	 s. e. (n 
 6). TRAP
differentiation (data not shown). It is worth noting that MNCs were characterized by examining the bone-resorbing activity
the target genes described above are continuously ex- on dentine slices and the expression of calcitonin receptors as
described previously (Takayanagi et al., 2000b).pressed in mature osteoclasts; therefore, it is likely that
these transcription factors remain active after the differ-
GeneChip Analysisentiation of BMMs into bone-resorbing osteoclasts.
BMMs were stimulated for 2, 24, and 72 hr with M-CSF alone, RANKLHow do these observations reconcile with the result
with M-CSF, or IL-1 (10 ng/ml) with M-CSF. Total RNA was extractedthat retrovirus-mediated expression of NFATc1 by itself
from BMMs using a Sepasol RNA extraction kit (Nakarai). Total RNA
efficiently induces osteoclast differentiation? We con- (15 g) was utilized for cDNA synthesis by reverse transcription
sidered the following explanation: the components of followed by synthesis of biotinylated cRNA through in vitro transcrip-
tion. After cRNA fragmentation, hybridization with mouse U74Av2AP-1 are expressed above threshold levels, so as to
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GeneChip (Affymetrix) displaying probes for 12,000 mouse genes/ cDNA into the same site of pMX-IRES-EGFP (a gift from T. Kitamura).
The other retrovirus vectors (pMX-c-fos-IRES-EGFP, pMX-c-jun-ESTs was performed according to the manufacturer’s protocol.
Chips were washed, stained with SA-PE, and analyzed using an IRES-EGFP) have been previously described (Takayanagi et al.,
2002). Retrovirus packaging was performed by cotransfection ofAffymetrix GeneChip scanner and accompanying gene expression
software. these pMX vectors and pPAMpsi2 (a gift from C.L. Sawyers) into
293T cells. Two days after inoculation, BMMs were assayed for
infection efficiency, and the rest of the cells were further culturedRNA Blotting Analysis and Immunofluorescence Staining
with M-CSF in the presence or absence of RANKL for the osteoclastBMMs were stimulated with RANKL in the presence of M-CSF for
formation assay. After 3 days, osteoclastogenesis was evaluated bythe indicated periods. Five micrograms of total RNA isolated with
TRAP staining and bone resorption assay. Detection of fluorescenceSepasol was loaded in each lane. The blots were hybridized with a
was performed before the staining for TRAP, whose autofluores-230 bp EcoRI and SmaI fragment of mouse NFATc1. cDNA (Gen-
cence interferes with others.Bank accession number AF087434) labeled with [-32P]dCTP. For
immunostaining, cells were fixed in 4% paraformaldehyde for 20
min and treated with 0.2% Triton X for 5 min. Cells were sequentially
RT-PCR Analysesincubated in 5% BSA/PBS for 30 min, 2 g/ml mouse anti-NFATc1
To evaluate the induction of mRNA of the endogenous NFATc1monoclonal antibody (7A6; Santa Cruz) in PBST for 60 min, and
gene, one of the PCR primers was designed to hybridize with thethen 4 g/ml Alexa 488 or 594-labeled anti-mouse IgG antibody
sequence in the 5UTR of NFATc1 gene, which is absent in virus-(Molecular Probe) for 60 min.
encoded NFATc1 cDNA. The primers for endogenous NFATc1
mRNA are 5-TGCTCCTCCTCCTGCTGCTC-3 and 5-CGTCTTCCABAPTA-AM Treatment
CCTCCACGTCG-3. Those for EGFP (5-ATCCTGGTCGAGCTGGFor chelating intracellular Ca2, cells were incubated in the presence
ACG-3 and 5-GGCCATGATATAGACGTTGTGGC-3) were used toof 15 M BAPTA-AM and 0.04% pluronic F127 for 60 min in serum-
determine that the retrovirus-derived EGFP mRNAs are equally ex-free -MEM. Cells were then washed twice with -MEM and incu-
pressed.bated in -MEM/FBS with RANKL/M-CSF for an osteoclast for-
mation assay as described above. This BAPTA-AM treatment was
performed once a day throughout the RANKL-induced osteoclasto-
Luciferase Reporter Gene Assay andgenesis.
Coimmunoprecipitation Assay
The reporter plasmid, pTRAP-luc, was constructed by inserting a
Ca2 Measurement 1.85 kb KpnI-BglII fragment of the mouse TRAP promoter into the
BMMs were incubated with RANKL or IL-1 (10 ng/ml) in the presence same sites of the PicaGene luciferase reporter plasmid, basic vector
of M-CSF for 72 hr. For Ca2 measurement, cells were incubated in 2 (Toyo Ink). The mouse calcitonin receptor promoter region specific
the presence of 5 M fluo-4 AM, 5 M Fura Red AM, and 0.05% to osteoclasts (P3 promoter) was amplified by PCR using sense
pluronic F127 for 30 min in serum-free DMEM. Cells were then 5-AAGATCTCAACACAACTCTTAACTGGACC-3 and antisense 5-
washed twice with DMEM and postincubated in the presence of AAGCTTAATGTAAATGTAGATATAGC-3 primers. Another reporter
DMEM with 10% FBS and 10 ng/ml M-CSF for 20 min. Cells loaded plasmid, pCTR-luc, was constructed by inserting a 461 bp PCR
with these dyes were washed three times with Hank’s balanced salt fragment into the BglII-HindIII sites of the basic vector 2. We de-
solution and mounted on the inverted stage of a confocal micro- signed an NFATc1 mutant based on the sequence homology with
scope (Leica). Cells were excited at 488 nm, and emissions at 505– NFATc2 mutants, which cannot interact with AP-1 (Macia´n et al.,
530 nm for fluo-4 and 600–680 nm for Fura Red were acquired 2000). An NFATc1 mutant (NFATc1RL) was produced by introducing
simultaneously at 5 s intervals. To estimate intracellular Ca2 con- mutations (R485A/L486A) using site-directed mutagenesis (Sawano
centration in single cells, the ratio of the fluorescence intensity of and Miyawaki, 2000). The primer was 5-TTGGGACGGCTGACGAC
the fluo-4 to Fura Red was calculated. The increase in the ratio from GCCGCGCTGAGGCCTCACGCCTTCTACCAGG-3. We transfected
the basal level was then divided by the maximum ratio increase 293T cells and RAW 264.7 cells using FuGene 6 (Roche) and Su-
obtained by adding 10 M ionomycin, and expressed as the percent perFect (QIAGEN), respectively, and luciferase activity was assayed
maximum ratio increase. 24 hr after transfection. RANKL was added to the culture of RAW
264.7 cells 3 hr after transfection. All data are expressed as mean	
Osteoclast Differentiation from ES Cells s.e. (n 
 6). At the same time point, whole-cell lysate was extracted
Feeder cell-independent ES cell lines were maintained on a gelatin- from 293T cells. Immunoprecipitates using anti-c-Fos antibody
coated dish in DMEM (GIBCO) containing 15% FBS, 1  104 M (Santa Cruz) and protein G sepharose (Amersham) were separated
2-mercaptoethanol, 1000 U/ml leukemia inhibitory factor (LIF), 50 with SDS-PAGE, followed by immunoblotting with anti-NFATc1 an-
U/ml streptomycin, and 50 mg/ml penicillin. We used wild-type ES tibody.
line E14K (NFATc1/), a heterozygous mutant clone NFDK34
(NFATc1/), and two homozygous mutant clones (NFATc1/),
NFDK10 and NFDK17, which generated identical results. For their Acknowledgments
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